Warning Letter Roundup: Five Firms Warned for Misbranding, GMPs
The FDA cited issued warnings letter to drugmakers in Japan, Mexico, Australia and to three in the United States for GMP and other deficiencies.
Source: Drug GMP Report
The FDA cited issued warnings letter to drugmakers in Japan, Mexico, Australia and to three in the United States for GMP and other deficiencies.
Source: Drug GMP Report